MAJESTEC-1 Update
The MAJESTEC-1 study was presented at ASCO, and appeared concomitantly in the New England Journal of Medicine. In this phase...
Volume 2, Issue 2
Clinical Spotlight
DETERMINATION Study
Prof Paul Richardson presented the DETERMINATIION trial at both ASCO and EHA, and the manuscript appeared at the same time...
CASSIOPEIA Maintenance
Lancet Oncology recently published a study on the CASSIOPEIA study, which is a two-part, open-label, randomized, phase 3 trial of patients...
HOVON 143 Study
An interesting study for the frail myeloma patients who are not eligible for ASCT is the phase II, Hovon 143...
MAIA Study
Recently, Lancet Oncology published an update of the MAIA study regarding overall survival (OS). MAIA is an ongoing, multicenter, randomized, open-label,...
Clinical Research
During the last 3 months, the results of two important phase-3 studies, using anti-CD38 monoclonal antibodies for the treatment of...
